• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小分子化合物ZYZ - 384靶向SMYD3以缓解衰老。

Small molecule compound ZYZ-384 targets SMYD3 to alleviate aging.

作者信息

Liu Yang, Han Dan, Jin Li, Xie Xuena, Li Huibo, Ding Qian, Zhu Yizhun

机构信息

State Key Laboratory of Quality Research in Chinese Medicine & Laboratory of Drug Discovery from Natural Resources and Industrialization, School of Pharmacy, Macau University of Science and Technology, Macau, China.

Macau University of Science and Technology, Macau, China.

出版信息

Sci Rep. 2025 Jul 10;15(1):24802. doi: 10.1038/s41598-025-10345-y.

DOI:10.1038/s41598-025-10345-y
PMID:40634549
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12241328/
Abstract

SMYD3 is a chromatin modifier that facilitates the trimethylation of histone 3 lysine 4 (H3K4) to induce diverse biological activities. We have provided a brief demonstration of the anti-aging effect of ZYZ-384, a newly developed inhibitor targeting SMYD3. In order to validate the anti-senescence effect of ZYZ-384, we utilized angiotensin II to induce senescence in two types of human endothelial cells (HMEC-1) and mouse endothelial cells (SVEC4-10), creating cellular models for senescence. Additionally, we employed D-galactose-induced subacute senescence animal models as well as natural senescence animal models. At the cellular level, we assessed proliferation capacity and intracellular markers associated with aging. Aging markers, SASP and differential metabolites were evaluated at an organismal level using animal models. Compared to senescent cells or animals, ZYZ-384 application significantly inhibited levels of aging markers in both senescent cell and senescent animal models while promoting cell proliferation. Furthermore, it suppressed expression of SMYD3 and H3K4me3 along with over expression of HSP 90 and NF-κB. Our study demonstrates that ZYZ-384 is an effective inhibitor targeting SMYD3 which can effectively delay aging.

摘要

SMYD3是一种染色质修饰因子,可促进组蛋白3赖氨酸4(H3K4)的三甲基化,从而诱导多种生物学活性。我们已简要证明了ZYZ-384(一种新开发的靶向SMYD3的抑制剂)的抗衰老作用。为了验证ZYZ-384的抗衰老作用,我们利用血管紧张素II在两种类型的人内皮细胞(HMEC-1)和小鼠内皮细胞(SVEC4-10)中诱导衰老,建立衰老细胞模型。此外,我们还采用了D-半乳糖诱导的亚急性衰老动物模型以及自然衰老动物模型。在细胞水平上,我们评估了增殖能力和与衰老相关的细胞内标志物。使用动物模型在机体水平评估衰老标志物、衰老相关分泌表型(SASP)和差异代谢物。与衰老细胞或动物相比,应用ZYZ-384可显著抑制衰老细胞和衰老动物模型中衰老标志物的水平,同时促进细胞增殖。此外,它还抑制了SMYD3和H3K4me3的表达,以及HSP 90和NF-κB的过表达。我们的研究表明,ZYZ-384是一种有效的靶向SMYD3的抑制剂,可有效延缓衰老。

相似文献

1
Small molecule compound ZYZ-384 targets SMYD3 to alleviate aging.小分子化合物ZYZ - 384靶向SMYD3以缓解衰老。
Sci Rep. 2025 Jul 10;15(1):24802. doi: 10.1038/s41598-025-10345-y.
2
Cytosolic DNA initiates a vicious circle of aging-related endothelial inflammation and mitochondrial dysfunction via STING: the inhibitory effect of Cilostazol.细胞质 DNA 通过 STING 引发与衰老相关的内皮炎症和线粒体功能障碍的恶性循环:西洛他唑的抑制作用。
Acta Pharmacol Sin. 2024 Sep;45(9):1879-1897. doi: 10.1038/s41401-024-01281-0. Epub 2024 Apr 30.
3
Senescence-associated alterations in histone H3 modifications, HP1 alpha levels and distribution, and in the transcriptome of vascular smooth muscle cells in different types of senescence.不同类型衰老过程中,组蛋白H3修饰、HP1α水平与分布以及血管平滑肌细胞转录组的衰老相关改变。
Cell Commun Signal. 2025 Jul 1;23(1):321. doi: 10.1186/s12964-025-02315-8.
4
Transcriptomic profiling of senescence effects on blood-brain barrier-related gene expression in brain capillary endothelial cells in a mouse model of paclitaxel-induced chemobrain.在紫杉醇诱导的化疗脑小鼠模型中,衰老对脑毛细血管内皮细胞血脑屏障相关基因表达影响的转录组分析
Geroscience. 2025 Feb 20. doi: 10.1007/s11357-025-01561-5.
5
Apoptotic priming in senescence predicts specific senolysis by quantitative analysis of mitochondrial dependencies.通过线粒体依赖性的定量分析,衰老中的凋亡引发可预测特定的衰老细胞溶解。
Cell Death Differ. 2025 May;32(5):802-817. doi: 10.1038/s41418-024-01431-1. Epub 2025 Jan 6.
6
[Analysis of the number, type, and functional heterogeneity of senescent cells in the radiation-induced skin wounds in mice].[小鼠辐射诱导皮肤伤口中衰老细胞的数量、类型及功能异质性分析]
Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi. 2025 Jun 20;41(6):577-586. doi: 10.3760/cma.j.cn501225-20240604-00209.
7
CDK4/6 inhibitor PD-0332991 suppresses hepatocarcinogenesis by inducing senescence of hepatic tumor-initiating cells.细胞周期蛋白依赖性激酶4/6抑制剂PD-0332991通过诱导肝肿瘤起始细胞衰老来抑制肝癌发生。
J Adv Res. 2025 Jul;73:357-373. doi: 10.1016/j.jare.2024.08.034. Epub 2024 Aug 31.
8
Targeting Senescence: A Review of Senolytics and Senomorphics in Anti-Aging Interventions.靶向衰老:衰老细胞溶解剂和衰老细胞形态调节剂在抗衰老干预中的综述
Biomolecules. 2025 Jun 13;15(6):860. doi: 10.3390/biom15060860.
9
The senolytic cocktail, dasatinib and quercetin, impacts the chromatin structure of both young and senescent vascular smooth muscle cells.衰老细胞溶解鸡尾酒疗法(达沙替尼和槲皮素)会影响年轻和衰老血管平滑肌细胞的染色质结构。
Geroscience. 2025 Jan 20. doi: 10.1007/s11357-024-01504-6.
10
Delphinidin attenuates cognitive deficits and pathology of Alzheimer's disease by preventing microglial senescence via AMPK/SIRT1 pathway.飞燕草素通过AMPK/SIRT1途径预防小胶质细胞衰老,从而减轻阿尔茨海默病的认知缺陷和病理变化。
Alzheimers Res Ther. 2025 Jun 20;17(1):138. doi: 10.1186/s13195-025-01783-x.

本文引用的文献

1
A novel small molecule ZYZ384 targeting SMYD3 for hepatocellular carcinoma via reducing H3K4 trimethylation of the Rac1 promoter.一种通过降低Rac1启动子的H3K4三甲基化靶向SMYD3治疗肝细胞癌的新型小分子ZYZ384。
MedComm (2020). 2024 Sep 15;5(10):e711. doi: 10.1002/mco2.711. eCollection 2024 Oct.
2
IRF3 activates RB to authorize cGAS-STING-induced senescence and mitigate liver fibrosis.IRF3 激活 RB 以授权 cGAS-STING 诱导的衰老并减轻肝纤维化。
Sci Adv. 2024 Mar;10(9):eadj2102. doi: 10.1126/sciadv.adj2102. Epub 2024 Feb 28.
3
EETs alleviate alveolar epithelial cell senescence by inhibiting endoplasmic reticulum stress through the Trim25/Keap1/Nrf2 axis.
EETs 通过 Trim25/Keap1/Nrf2 轴抑制内质网应激来减轻肺泡上皮细胞衰老。
Redox Biol. 2023 Jul;63:102765. doi: 10.1016/j.redox.2023.102765. Epub 2023 May 28.
4
Organismal Roles of Hsp90.Hsp90 的机体角色。
Biomolecules. 2023 Jan 29;13(2):251. doi: 10.3390/biom13020251.
5
Cellular Senescence: From Mechanisms to Current Biomarkers and Senotherapies.细胞衰老:从机制到当前生物标志物和衰老疗法。
Pharmacol Rev. 2023 Jul;75(4):675-713. doi: 10.1124/pharmrev.122.000622. Epub 2023 Feb 2.
6
EdU sensing: The Raman way of following endothelial cell proliferation in vitro and ex vivo.EdU 检测:体外和体外表观内皮细胞增殖的拉曼研究方法。
Biosens Bioelectron. 2022 Nov 15;216:114624. doi: 10.1016/j.bios.2022.114624. Epub 2022 Aug 10.
7
Cellular senescence: a key therapeutic target in aging and diseases.细胞衰老:衰老和疾病的关键治疗靶点。
J Clin Invest. 2022 Aug 1;132(15). doi: 10.1172/JCI158450.
8
Oxidative Stress in Human Pathology and Aging: Molecular Mechanisms and Perspectives.氧化应激与人类疾病和衰老:分子机制与展望。
Cells. 2022 Feb 5;11(3):552. doi: 10.3390/cells11030552.
9
The role of cellular senescence in cardiac disease: basic biology and clinical relevance.细胞衰老在心脏疾病中的作用:基础生物学与临床相关性。
Nat Rev Cardiol. 2022 Apr;19(4):250-264. doi: 10.1038/s41569-021-00624-2. Epub 2021 Oct 19.
10
HSP90 acts as a senomorphic target in senescent retinal pigmental epithelial cells.HSP90 在衰老的视网膜色素上皮细胞中充当衰老相关的靶标。
Aging (Albany NY). 2021 Sep 8;13(17):21547-21570. doi: 10.18632/aging.203496.